PAPL Q3 2025 Earnings EPS Surprises Positively Despite Revenue Uncertainty Stock Declines FFIN Q1 2026 Earnings EPS Beat Surprise of 38 Drives Positive Stock Movement Aditxt Inc ADTX Q3 2025 Earnings Significant Loss Per Share and No Revenue Amid Sharp Stock Decline OCUL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Development NVNI Q4 2025 Earnings Massive EPS Miss Sends Shockwaves as Revenue Figures Remain Undisclosed Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up